Oxidative stress in hypertension: Role of the kidney

Antioxidants and Redox Signaling

Volumn 20, Issue 1, 2014, Pages 74-101

  Araujo, Magali ^a   Wilcox, Christopher S ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; HYDROGEN PEROXIDE; OXYGEN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RENIN; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ALDOSTERONE RELEASE; ARTERIOLE; AUTOREGULATION; BLOOD VESSEL REACTIVITY; EFFERENT NERVE; ENDOTHELIAL DYSFUNCTION; FEEDBACK SYSTEM; GENE DELETION; GLOMERULUS; HENLE LOOP; HUMAN; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY PROXIMAL TUBULE; KIDNEY STRUCTURE; KIDNEY TUBULE ABSORPTION; NATRIURESIS; NONHUMAN; OXIDATIVE STRESS; OXYGENATION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SENSORY NERVE; TUBULAR DYSFUNCTION;

ANIMALS; BIOLOGICAL TRANSPORT; HEMODYNAMICS; HUMANS; HYPERTENSION; KIDNEY; KIDNEY GLOMERULUS; KIDNEY TUBULES; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RENAL CIRCULATION; RENIN-ANGIOTENSIN SYSTEM;

EID: 84891763490     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5259     Document Type: Review

References (351)

1. Abadir PM, Foster DB, Crow M, Cooke CA, Rucker JJ, Jain A, Smith BJ, Burks TN, Cohn RD, Fedarko NS, Carey RM, O?Rourke B, and Walston JD. Identification and characterization of a functional mitochondrial angiotensin system. Proc Natl Acad Sci U S A 108: 14849-14854, 2011.
2. Adler S and Huang H. Oxidant stress in kidneys of spontaneously hypertensive rats involves both oxidase overexpression and loss of extracellular superoxide dismutase. Am J Physiol Renal Physiol 287: F907-F913, 2004.
3. Ahmeda AF and Johns EJ. The regulation of blood perfusion in the renal cortex and medulla by reactive oxygen species and nitric oxide in the anaesthetised rat. Acta Physiol (Oxf) 204: 443-450, 2012.
4. Aldred KL, Harris PJ, and Eitle E. Increased proximal tubule NHE-3 and H+ -ATPase activities in spontaneously hypertensive rats. J Hypertens 18: 623-628, 2000.
5. Alexander MY, Brosnan MJ, Hamilton CA, Fennell JP, Beattie EC, Jardine E, Heistad DD, and Dominiczak AF. Gene transfer of endothelial nitric oxide synthase but not Cu/Zn superoxide dismutase restores nitric oxide availability in the SHRSP. Cardiovasc Res 47: 609-617, 2000.
6. Allen AM. Blockade of angiotensin AT1-receptors in the rostral ventrolateral medulla of spontaneously hypertensive rats reduces blood pressure and sympathetic nerve discharge. J Renin Angiotensin Aldosterone Syst 2: S120-S124, 2001.
7. Aoi W, Niisato N, Sawabe Y, Miyazaki H, Tokuda S, Nishio K, Yoshikawa T, and Marunaka Y. Abnormal expression of ENaC and SGK1 mRNA induced by dietary sodium in Dahl salt-sensitively hypertensive rats. Cell Biol Int 31: 1288-1291, 2007.
8. Armando I, Wang X, Villar VA, Jones JE, Asico LD, Escano C, and Jose PA. Reactive oxygen species-dependent hypertension in dopamine D2 receptor-deficient mice. Hypertension 49: 672-678, 2007.
9. Bachmann S and Mundel P. Nitric oxide in the kidney: synthesis, localization, and function. Am J Kidney Dis 24: 112-129, 1994.
10. Bagnall NM, Dent PC, Walkowska A, Sadowski J, and Johns EJ. Nitric oxide inhibition and the impact on renal nerve-mediated antinatriuresis and antidiuresis in the anaesthetized rat. J Physiol 569: 849-856, 2005.
11. Baines A and Ho P. Glucose stimulates O2 consumption, NOS, and Na/H exchange in diabetic rat proximal tubules. Am J Physiol Renal Physiol 283: F286-F293, 2002.
12. Banday AA and Lokhandwala MF. Dopamine receptors and hypertension. Curr Hypertens Rep 10: 268-275, 2008.
13. Bassett MH, Suzuki T, Sasano H, White PC, and Rainey WE. The orphan nuclear receptors NURR1 and NGFIB regulate adrenal aldosterone production. Mol Endocrinol 18: 279-290, 2004.
14. Bayorh MA, Ganafa AA, Eatman D, Walton M, and Feuerstein GZ. Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension. Am J Hypertens 18: 1496-1502, 2005.
15. Bayorh MA, Rollins-Hairston A, Adiyiah J, Lyn D, and Eatman D. Eplerenone suppresses aldosterone/saltinduced expression of NOX-4. J Renin Angiotensin Aldosterone Syst 12: 195-201, 2011.
16. Bhaskaran M, Reddy K, Radhakrishanan N, Franki N, Ding G, and Singhal PC. Angiotensin II induces apoptosis in renal proximal tubular cells. Am J Physiol Renal Physiol 284: F955-F965, 2003.
17. Blantz RC, Deng A, Lortie M, Munger K, Vallon V, Gabbai FB, and Thomson SC. The complex role of nitric oxide in the regulation of glomerular ultrafiltration. Kidney Int 61: 782-785, 2002.
18. Boivin V, Jahns R, Gambaryan S, Ness W, Boege F, and Lohse MJ. Immunofluorescent imaging of beta 1-And beta 2-Adrenergic receptors in rat kidney. Kidney Int 59: 515-531, 2001.
19. Bosse HM and Bachmann S. Immunohistochemically detected protein nitration indicates sites of renal nitric oxide release in Goldblatt hypertension. Hypertension 30: 948-952, 1997.
20. Briet M and Schiffrin EL. Aldosterone: effects on the kidney and cardiovascular system. Nat Rev Nephrol 6: 261-273, 2010.
21. Brown R, Ollerstam A, Johansson B, Skott O, Gebre-Medhin S, Fredholm B, and Persson AE. Abolished tubuloglomerular feedback and increased plasma renin in adenosine A1 receptor-deficient mice. Am J Physiol Regul Integr Comp Physiol 281: R1362-R1367, 2001.
22. Bugaj V, Pochynyuk O, Mironova E, Vandewalle A, Medina JL, and Stockand JD. Regulation of the epithelial Na+ channel by endothelin-1 in rat collecting duct. Am J Physiol Renal Physiol 295: F1063-F1070, 2008.
23. Cai H, Davis ME, Drummond GR, and Harrison DG. Induction of endothelial NO synthase by hydrogen peroxide via a Ca(2 + )/calmodulin-dependent protein kinase II/ janus kinase 2-dependent pathway. Arterioscler Thromb Vasc Biol 21: 1571-1576, 2001.
24. Campese VM, Shaohua Y, and Huiquin Z. Oxidative stress mediates angiotensin II-dependent stimulation of sympathetic nerve activity. Hypertension 46: 533-539, 2005.
25. Campese VM and Ye S. A vitamin-E-fortified diet reduces oxidative stress, sympathetic nerve activity, and hypertension in the phenol-renal injury model in rats. J Am Soc Hypertens 1: 242-250, 2007.
26. Campese VM, Ye S, Zhong H, Yanamadala V, Ye Z, and Chiu J. Reactive oxygen species stimulate central and peripheral sympathetic nervous system activity. Am J Physiol Heart Circ Physiol 287: H695-H703, 2004.
27. Carlstrom M, Lai EY, Ma Z, Patzak A, Brown RD, and Persson AE. Role of NOX2 in the regulation of afferent arteriole responsiveness. Am J Physiol Regul Integr Comp Physiol 296: R72-R79, 2009.
28. Carlstrom M, Lai EY, Ma Z, Steege A, Patzak A, Eriksson UJ, Lundberg JO, Wilcox CS, and Persson AE. Superoxide dismutase 1 limits renal microvascular remodeling and attenuates arteriole and blood pressure responses to angiotensin II via modulation of nitric oxide bioavailability. Hypertension 56: 907-913, 2010.
29. Chabrashvili T, Kitiyakara C, Blau J, Karber A, Aslam S, Welch WJ, and Wilcox CS. Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression. Am J Physiol Regul Integr Comp Physiol 285: R117-R124, 2003.
30. Chabrashvili T, Tojo A, Onozato ML, Kitiyakara C, Quinn MT, Fujita T, Welch WJ, and Wilcox CS. Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 39: 269-274, 2002.
31. Chan SH, Tai MH, Li CY, and Chan JY. Reduction in molecular synthesis or enzyme activity of superoxide dismutases and catalase contributes to oxidative stress and neurogenic hypertension in spontaneously hypertensive rats. Free Radic Biol Med 40: 2028-2039, 2006.
32. Chandramohan G, Bai Y, Norris K, Rodriguez-Iturbe B, and Vaziri ND. Effects of dietary salt on intrarenal angiotensin system, NAD(P)H oxidase, COX-2, MCP-1 and PAI-1 expressions and NF-kappaB activity in saltsensitive and -resistant rat kidneys. Am J Nephrol 28: 158-167, 2008.
33. Chen X, Patel K, Connors SG, Mendonca M, Welch WJ, and Wilcox CS. Acute antihypertensive action of Tempol in the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol 293: H3246-H3253, 2007.
34. Chen Y, Gill PS, and Welch WJ. Oxygen availability limits renal NADPH-dependent superoxide production. Am J Physiol Renal Physiol 289: F749-F753, 2005.
35. Chen Y, Pearlman A, Luo Z, and Wilcox CS. Hydrogen peroxide mediates a transient vasorelaxation with tempol during oxidative stress. Am J Physiol Heart Circ Physiol 293: H2085-H2092, 2007.
36. Chen YF, Cowley AW, Jr., and Zou AP. Increased H(2)O(2) counteracts the vasodilator and natriuretic effects of superoxide dismutation by tempol in renal medulla. Am J Physiol Regul Integr Comp Physiol 285: R827-R833, 2003.
37. Cheng G, Cao Z, Xu X, van Meir EG, and Lambeth JD. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 269: 131-140, 2001.
38. Chrissobolis S and Faraci FM. Sex differences in protection against angiotensin II-induced endothelial dysfunction by manganese superoxide dismutase in the cerebral circulation. Hypertension 55: 905-910, 2010.
39. Chu Y, Iida S, Lund DD, Weiss RM, DiBona GF, Watanabe Y, Faraci FM, and Heistad DD. Gene transfer of extracellular superoxide dismutase reduces arterial pressure in spontaneously hypertensive rats: role of heparin-binding domain. Circ Res 92: 461-468, 2003.
40. Copin JC, Gasche Y, and Chan PH. Overexpression of copper/zinc superoxide dismutase does not prevent neonatal lethality in mutant mice that lack manganese superoxide dismutase. Free Radic Biol Med 28: 1571-1576, 2000.
41. Cowley AW, Jr. Renal medullary oxidative stress, pressurenatriuresis, and hypertension. Hypertension 52: 777-786, 2008.
42. Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, Kumar AP, Kim HS, Smithies O, Le TH, and Coffman TM. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci U S A 103: 17985-17990, 2006.
43. Cruthirds DL, Saba H, and MacMillan-Crow LA. Overexpression of manganese superoxide dismutase protects against ATP depletion-mediated cell death of proximal tubule cells. Arch Biochem Biophys 437: 96-105, 2005.
44. Cseko C, Bagi Z, and Koller A. Biphasic effect of hydrogen peroxide on skeletal muscle arteriolar tone via activation of endothelial and smooth muscle signaling pathways. J Appl Physiol 97: 1130-1137, 2004.
45. Cuevas S, Zhang Y, Yang Y, Escano C, Asico L, Jones JE, Armando I, and Jose PA. Role of renal DJ-1 in the pathogenesis of hypertension associated with increased reactive oxygen species production. Hypertension 59: 446-452, 2012.
46. Dai X, Galligan JJ, Watts SW, Fink GD, and Kreulen DL. Increased O2-production and upregulation of ETB receptors by sympathetic neurons in DOCA-salt hypertensive rats. Hypertension 43: 1048-1054, 2004.
47. de Cavanagh EM, Piotrkowski B, Basso N, Stella I, Inserra F, Ferder L, and Fraga CG. Enalapril and losartan attenuate mitochondrial dysfunction in aged rats. FASEB J 17: 1096-1098, 2003.
48. De Keulenaer GW, Alexander RW, Ushio-Fukai M, Ishizaka N, and Griendling KK. Tumour necrosis factor alpha activates a p22phox-based NADH oxidase in vascular smooth muscle. Biochem J 329 (Pt 3): 653-657, 1998.
49. Demchenko IT, Oury TD, Crapo JD, and Piantadosi CA. Regulation of the brain?s vascular responses to oxygen. Circ Res 91: 1031-1037, 2002.
50. Deng X, Welch WJ, and Wilcox CS. Role of nitric oxide in short-term and prolonged effects of angiotensin II on renal hemodynamics. Hypertension 27: 1173-1179, 1996.
51. DiBona GF and Esler M. Translational medicine: the antihypertensive effect of renal denervation. Am J Physiol Regul Integr Comp Physiol 298: R245-R253, 2010.
52. Dickhout JG, Mori T, and Cowley AW, Jr. Tubulovascular nitric oxide crosstalk: buffering of angiotensin II-induced medullary vasoconstriction. Circ Res 91: 487-493, 2002.
53. Didion SP, Ryan MJ, Didion LA, Fegan PE, Sigmund CD, and Faraci FM. Increased superoxide and vascular dysfunction in CuZnSOD-deficient mice. Circ Res 91: 938-944, 2002.
54. Dikalov SI and Nazarewicz RR. Angiotensin II-induced production of mitochondrial reactive oxygen species: potential mechanisms and relevance for cardiovascular disease. Antioxid Redox Signal 19: 1085-1094, 2013.
55. Ding G, Reddy K, Kapasi AA, Franki N, Gibbons N, Kasinath BS, and Singhal PC. Angiotensin II induces apoptosis in rat glomerular epithelial cells. Am J Physiol Renal Physiol 283: F173-F180, 2002.
56. Drummond GR, Cai H, Davis ME, Ramasamy S, and Harrison DG. Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide. Circ Res 86: 347-354, 2000.
57. Dworkin LD, Grosser M, Feiner HD, Ullian M, and Parker M. Renal vascular effects of antihypertensive therapy in uninephrectomized SHR. Kidney Int 35: 790-798, 1989.
58. Ebrahimian T, He Y, Schiffrin EL, and Touyz RM. Differential regulation of thioredoxin and NAD(P)H oxidase by angiotensin II in male and female mice. J Hypertens 25: 1263-1271, 2007.
59. Ebrahimian T and Touyz RM. Thioredoxin in vascular biology: role in hypertension. Antioxid Redox Signal 10: 1127-1136, 2008.
60. Eklof AC. The natriuretic response to a dopamine DA1 agonist requires endogenous activation of dopamine DA2 receptors. Acta Physiol Scand 160: 311-314, 1997.
61. Feletou M, Verbeuren TJ, and Vanhoutte PM. Endotheliumdependent contractions in SHR: a tale of prostanoid TP and IP receptors. Br J Pharmacol 156: 563-574, 2009.
62. Feng D, Yang C, Geurts AM, Kurth T, Liang M, Lazar J, Mattson DL, O?Connor PM, and Cowley AW, Jr. Increased expression of NAD(P)H oxidase subunit p67(phox) in the renal medulla contributes to excess oxidative stress and salt-sensitive hypertension. Cell Metab 15: 201-208, 2012.
63. Fennell JP, Brosnan MJ, Frater AJ, Hamilton CA, Alexander MY, Nicklin SA, Heistad DD, Baker AH, and Dominiczak AF. Adenovirus-mediated overexpression of extracellular superoxide dismutase improves endothelial dysfunction in a rat model of hypertension. Gene Ther 9: 110-117, 2002.
64. Fine LG, Bandyopadhay D, and Norman JT. Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia. Kidney Int Suppl 75: S22-S26, 2000.
65. Fischer LR, Li Y, Asress SA, Jones DP, and Glass JD. Absence of SOD1 leads to oxidative stress in peripheral nerve and causes a progressive distal motor axonopathy. Exp Neurol 233: 163-171, 2012.
66. Folz RJ and Crapo JD. Extracellular superoxide dismutase (SOD3): tissue-specific expression, genomic characterization, and computer-Assisted sequence analysis of the human EC SOD gene. Genomics 22: 162-171, 1994.
67. Folz RJ, Guan J, Seldin MF, Oury TD, Enghild JJ, and Crapo JD. Mouse extracellular superoxide dismutase: primary structure, tissue-specific gene expression, chromosomal localization, and lung in situ hybridization. Am J Respir Cell Mol Biol 17: 393-403, 1997.
68. Franco M, Bautista R, Perez-Mendez O, Gonzalez L, Pacheco U, Sanchez-Lozada LG, Santamaria J, Tapia E, Monreal R, and Martinez F. Renal interstitial adenosine is increased in angiotensin II-induced hypertensive rats. Am J Physiol Renal Physiol 294: F84-F92, 2008.
69. Franco M, Perez-Mendez O, and Martinez F. Interaction of intrarenal adenosine and angiotensin II in kidney vascular resistance. Curr Opin Nephrol Hypertens 18: 63-67, 2009.
70. Fu Y, Zhang R, Lu D, Liu H, Chandrashekar K, Juncos LA, and Liu R. NOX2 is the primary source of angiotensin IIinduced superoxide in the macula densa. Am J Physiol Regul Integr Comp Physiol 298: R707-R712, 2010.
71. Fujii S, Zhang L, Igarashi J, and Kosaka H. L-Arginine reverses p47phox and gp91phox expression induced by high salt in Dahl rats. Hypertension 42: 1014-1020, 2003.
72. Fujiki T, Shimokawa H, Morikawa K, Kubota H, Hatanaka M, Talukder MA, Matoba T, Takeshita A, and Sunagawa K. Endothelium-derived hydrogen peroxide accounts for the enhancing effect of an angiotensin-converting enzyme inhibitor on endothelium-derived hyperpolarizing factor-mediated responses in mice. Arterioscler Thromb Vasc Biol 25: 766-771, 2005.
73. Fujimoto S, Satoh M, Horike H, Hatta H, Haruna Y, Kobayashi S, Namikoshi T, Arakawa S, Tomita N, and Kashihara N. Olmesartan ameliorates progressive glomerular injury in subtotal nephrectomized rats through suppression of superoxide production. Hypertens Res 31: 305-313, 2008.
74. Fukai T. Mitochondrial thioredoxin: novel regulator for NADPH oxidase and angiotensin II-induced hypertension. Hypertension 54: 224-225, 2009.
75. Fukai T, Siegfried MR, Ushio-Fukai M, Griendling KK, and Harrison DG. Modulation of extracellular superoxide dismutase expression by angiotensin II and hypertension. Circ Res 85: 23-28, 1999.
76. Fukai T and Ushio-Fukai M. Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxid Redox Signal 15: 1583-1606, 2011.
77. Galle J, Herzog C, Schollmeyer P, and Wanner C. Oxygenderived radicals stimulate renin release of isolated juxtaglomerular cells. FEBS Lett 351: 314-316, 1994.
78. Galle J, Stunz P, Schollmeyer P, and Wanner C. Oxidized LDL and lipoprotein(a) stimulate renin release of juxtaglomerular cells. Kidney Int 47: 45-52, 1995.
79. Gao X, Patzak A, Sendeski M, Scheffer PG, Teerlink T, Sallstrom J, Fredholm BB, Persson AE, and Carlstrom M. Adenosine A(1)-receptor deficiency diminishes afferent arteriolar and blood pressure responses during nitric oxide inhibition and angiotensin II treatment. Am J Physiol Regul Integr Comp Physiol 301: R1669-R1681, 2011.
80. Gao YJ, Hirota S, Zhang DW, Janssen LJ, and Lee RM. Mechanisms of hydrogen-peroxide-induced biphasic response in rat mesenteric artery. Br J Pharmacol 138: 1085-1092, 2003.
81. Gao YJ and Lee RM. Hydrogen peroxide induces a greater contraction in mesenteric arteries of spontaneously hypertensive rats through thromboxane A(2) production. Br J Pharmacol 134: 1639-1646, 2001.
82. Garcia NH, Plato CF, Stoos BA, and Garvin JL. Nitric oxide-induced inhibition of transport by thick ascending limbs from Dahl salt-sensitive rats. Hypertension 34: 508-513, 1999.
83. Garcia-Estan J and Roman RJ. Role of renal interstitial hydrostatic pressure in the pressure diuresis response. Am J Physiol 256: F63-F70, 1989.
84. Garvin JL, Herrera M, and Ortiz PA. Regulation of renal NaCl transport by nitric oxide, endothelin, and ATP: clinical implications. Annu Rev Physiol 73: 359-376, 2011.
85. Garvin JL and Hong NJ. Nitric oxide inhibits sodium/hydrogen exchange activity in the thick ascending limb. Am J Physiol 277: F377-F382, 1999.
86. Garvin JL and Ortiz PA. The role of reactive oxygen species in the regulation of tubular function. Acta Physiol Scand 179: 225-232, 2003.
87. Geiszt M, Kopp JB, Varnai P, and Leto TL. Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci U S A 97: 8010-8014, 2000.
88. Gill PS and Wilcox CS. NADPH oxidases in the kidney. Antioxid Redox Signal 8: 1597-1607, 2006.
89. Gongora MC, Qin Z, Laude K, Kim HW, McCann L, Folz JR, Dikalov S, Fukai T, and Harrison DG. Role of extracellular superoxide dismutase in hypertension. Hypertension 48: 473-481, 2006.
90. Gorin Y, Ricono JM, Kim NH, Bhandari B, Choudhury GG, and Abboud HE. Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells. Am J Physiol Renal Physiol 285: F219-F229, 2003.
91. Granger JP, Alexander BT, and Llinas M. Mechanisms of pressure natriuresis. Curr Hypertens Rep 4: 152-159, 2002.
92. Grassi G, Seravalle G, Brambilla G, and Mancia G. The sympathetic nervous system and new nonpharmacologic approaches to treating hypertension: a focus on renal denervation. Can J Cardiol 28: 311-317, 2012.
93. Grote K, Ortmann M, Salguero G, Doerries C, Landmesser U, Luchtefeld M, Brandes RP, Gwinner W, Tschernig T, Brabant EG, Klos A, Schaefer A, Drexler H, and Schieffer B. Critical role for p47phox in renin-Angiotensin system activation and blood pressure regulation. Cardiovasc Res 71: 596-605, 2006.
94. Guo P, Nishiyama A, Rahman M, Nagai Y, Noma T, Namba T, Ishizawa M, Murakami K, Miyatake A, Kimura S, Mizushige K, Abe Y, Ohmori K, and Kohno M. Contribution of reactive oxygen species to the pathogenesis of left ventricular failure in Dahl salt-sensitive hypertensive rats: effects of angiotensin II blockade. J Hypertens 24: 1097-1104, 2006.
95. Guo W, Adachi T, Matsui R, Xu S, Jiang B, Zou MH, Kirber M, Lieberthal W, and Cohen RA. Quantitative assessment of tyrosine nitration of manganese superoxide dismutase in angiotensin II-infused rat kidney. Am J Physiol Heart Circ Physiol 285: H1396-H1403, 2003.
96. Gwathmey TM, Alzayadneh EM, Pendergrass KD, and Chappell MC. Novel roles of nuclear angiotensin receptors and signaling mechanisms. Am J Physiol Regul Integr Comp Physiol 302: R518-R530, 2012.
97. Gwathmey TM, Shaltout HA, Pendergrass KD, Pirro NT, Figueroa JP, Rose JC, Diz DI, and Chappell MC. Nuclear angiotensin II type 2 (AT2) receptors are functionally linked to nitric oxide production. Am J Physiol Renal Physiol 296: F1484-F1493, 2009.
98. Haendeler J, Popp R, Goy C, Tischler V, Zeiher AM, and Dimmeler S. Cathepsin D and H2O2 stimulate degradation of thioredoxin-1: implication for endothelial cell apoptosis. J Biol Chem 280: 42945-42951, 2005.
99. Haendeler J, Tischler V, Hoffmann J, Zeiher AM, and Dimmeler S. Low doses of reactive oxygen species protect endothelial cells from apoptosis by increasing thioredoxin-1 expression. FEBS Lett 577: 427-433, 2004.
100. Hansen PB, Hashimoto S, Briggs J, and Schnermann J. Attenuated renovascular constrictor responses to angiotensin II in adenosine 1 receptor knockout mice. Am J Physiol Regul Integr Comp Physiol 285: R44-R49, 2003.
101. Haque MZ and Majid DS. High salt intake delayed angiotensin II-induced hypertension in mice with a genetic variant of NADPH oxidase. Am J Hypertens 24: 114-118, 2011.
102. Harris RC. Podocyte ACE2 protects against diabetic nephropathy. Kidney Int 82: 255-256, 2012.
103. Harrison DG, Cai H, Landmesser U, and Griendling KK. Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease. J Renin Angiotensin Aldosterone Syst 4: 51-61, 2003.
104. Harrison DG, Gongora MC, Guzik TJ, and Widder J. Oxidative stress and hypertension. J Am Soc Hypertens 1: 30-44, 2007.
105. Harrison-Bernard LM, Cook AK, Oliverio MI, and Coffman TM. Renal segmental microvascular responses to ANG II in AT1A receptor null mice. Am J Physiol Renal Physiol 284: F538-F545, 2003.
106. Harrison-Bernard LM, Navar LG, Ho MM, Vinson GP, and el-Dahr SS. Immunohistochemical localization of ANG II AT1 receptor in adult rat kidney using a monoclonal antibody. Am J Physiol 273: F170-F177, 1997.
107. Herrera M and Garvin JL. Angiotensin II stimulates thick ascending limb NO production via AT(2) receptors andAkt1-dependent nitric-oxide synthase 3 (NOS3) activation. J Biol Chem 285: 14932-14940, 2010.
108. Herrera M, Ortiz PA, and Garvin JL. Regulation of thick ascending limb transport: role of nitric oxide. Am J Physiol Renal Physiol 290: F1279-F1284, 2006.
109. Hill GS and Heptinstall RH. Steroid-induced hypertension in the rat. A microangiographic and histologic study on the pathogenesis of hypertensive vascular and glomerular lesions. Am J Pathol 52: 1-40, 1968.
110. Ho YS, Xiong Y, Ma W, Spector A, and Ho DS. Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury. J Biol Chem 279: 32804-32812, 2004.
111. Hoagland KM, Maier KG, and Roman RJ. Contributions of 20-HETE to the antihypertensive effects of Tempol in Dahl salt-sensitive rats. Hypertension 41: 697-702, 2003.
112. Hoch NE, Guzik TJ, Chen W, Deans T, Maalouf SA, Gratze P, Weyand C, and Harrison DG. Regulation of T-cell function by endogenously produced angiotensin II. Am J Physiol Regul Integr Comp Physiol 296: R208-R216, 2009.
113. Hong NJ and Garvin JL. NADPH oxidase 4 mediates flowinduced superoxide production in thick ascending limbs. Am J Physiol Renal Physiol 303: F1151-F1156, 2012.
114. Hong NJ, Silva GB, and Garvin JL. PKC-Alpha mediates flow-stimulated superoxide production in thick ascending limbs. Am J Physiol Renal Physiol 298: F885-F891, 2010.
115. Hua P, Feng W, Rezonzew G, Chumley P, and Jaimes EA. The transcription factor ETS-1 regulates angiotensin IIstimulated fibronectin production in mesangial cells. Am J Physiol Renal Physiol 302: F1418-F1429, 2012.
116. Huang BS, Ahmadi S, Ahmad M, White RA, and Leenen FH. Central neuronal activation and pressor responses induced by circulating ANG II: role of the brain aldosterone-ouabain pathway. Am J Physiol Heart Circ Physiol 299: H422-H430, 2010.
117. Hussain T and Lokhandwala MF. Altered arachidonic acid metabolism contributes to the failure of dopamine to inhibit Na+ ,K( + )-ATPase in kidney of spontaneously hypertensive rats. Clin Exp Hypertens 18: 963-974, 1996.
118. Hwang I, Lee J, Huh JY, Park J, Lee HB, Ho YS, and Ha H. Catalase deficiency accelerates diabetic renal injury through peroxisomal dysfunction. Diabetes 61: 728-738, 2012.
119. Itani H, Liu X, Sarsour EH, Goswami PC, Born E, Keen HL, and Sigmund CD. Regulation of renin gene expression by oxidative stress. Hypertension 53: 1070-1076, 2009.
120. Ito S, Juncos LA, and Carretero OA. Pressure-induced constriction of the afferent arteriole of spontaneously hypertensive rats. Hypertension 19: II164-II167, 1992.
121. Iversen BM, Amann K, Kvam FI, Wang X, and Ofstad J. Increased glomerular capillary pressure and size mediate glomerulosclerosis in SHR juxtamedullary cortex. Am J Physiol 274: F365-F373, 1998.
122. Iwai N and Inagami T. Identification of two subtypes in the rat type I angiotensin II receptor. FEBS Lett 298: 257-260, 1992.
123. Jennings BL, Anderson LJ, Estes AM, Yaghini FA, Fang XR, Porter J, Gonzalez FJ, Campbell WB, and Malik KU. Cytochrome P450 1B1 contributes to renal dysfunction and damage caused by angiotensin II in mice. Hypertension 59: 348-354, 2012.
124. Jia J, Ding G, Zhu J, Chen C, Liang W, Franki N, and Singhal PC. Angiotensin II infusion induces nephrin expression changes and podocyte apoptosis. Am J Nephrol 28: 500-507, 2008.
125. Jin C, Hu C, Polichnowski A, Mori T, Skelton M, Ito S, and Cowley AW, Jr. Effects of renal perfusion pressure on renal medullary hydrogen peroxide and nitric oxide production. Hypertension 53: 1048-1053, 2009.
126. Jin XQ, Fukuda N, Su JZ, Lai YM, Suzuki R, Tahira Y, Takagi H, Ikeda Y, Kanmatsuse K, and Miyazaki H. Angiotensin II type 2 receptor gene transfer downregulates angiotensin II type 1a receptor in vascular smooth muscle cells. Hypertension 39: 1021-1027, 2002.
127. Jose PA, Eisner GM, and Felder RA. Role of dopamine receptors in the kidney in the regulation of blood pressure. Curr Opin Nephrol Hypertens 11: 87-92, 2002.
128. Jung O, Marklund SL, Geiger H, Pedrazzini T, Busse R, and Brandes RP. Extracellular superoxide dismutase is a major determinant of nitric oxide bioavailability: in vivo and ex vivo evidence from ecSOD-deficient mice. Circ Res 93: 622-629, 2003.
129. Jung O, Schreiber JG, Geiger H, Pedrazzini T, Busse R, and Brandes RP. gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension. Circulation 109: 1795-1801, 2004.
130. Just A and Arendhorst WJ. The role of reactive oxygen species in renal blood flow autoregulation. FASEB J 22: 761.19, 2008.
131. Just A and Arendshorst WJ. A novel mechanism of renal blood flow autoregulation and the autoregulatory role of A1 adenosine receptors in mice. Am J Physiol Renal Physiol 293: F1489-F1500, 2007.
132. Just A, Whitten CL, and Arendshorst WJ. Reactive oxygen species participate in acute renal vasoconstrictor responses induced by ETA and ETB receptors. Am J Physiol Renal Physiol 294: F719-F728, 2008.
133. Kawada N, Dennehy K, Solis G, Modlinger P, Hamel R, Kawada JT, Aslam S, Moriyama T, Imai E, Welch WJ, and Wilcox CS. TP receptors regulate renal hemodynamics during angiotensin II slow pressor response. Am J Physiol Renal Physiol 287: F753-F759, 2004.
134. Kawada N, Imai E, Karber A, Welch WJ, and Wilcox CS. A mouse model of angiotensin II slow pressor response: role of oxidative stress. J Am Soc Nephrol 13: 2860-2868, 2002.
135. Kawarazaki W, Nagase M, Yoshida S, Takeuchi M, Ishizawa K, Ayuzawa N, Ueda K, and Fujita T. Angiotensin IIand salt-induced kidney injury through Rac1-mediated mineralocorticoid receptor activation. J Am Soc Nephrol 23: 997-1007, 2012.
136. Kishi T, Hirooka Y, Kimura Y, Ito K, Shimokawa H, and Takeshita A. Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation 109: 2357-2362, 2004.
137. Kitayama J, Yi C, Faraci FM, and Heistad DD. Modulation of dilator responses of cerebral arterioles by extracellular superoxide dismutase. Stroke 37: 2802-2806, 2006.
138. Kitiyakara C, Chabrashvili T, Chen Y, Blau J, Karber A, Aslam S, WelchWJ, andWilcox CS. Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase. J Am Soc Nephrol 14: 2775-2782, 2003.
139. Klar J, Vitzthum H, and Kurtz A. Aldosterone enhances renin gene expression in juxtaglomerular cells. Am J Physiol Renal Physiol 286: F349-F355, 2004.
140. Kobayashi M, Sugiyama H, Wang DH, Toda N, Maeshima Y, Yamasaki Y, Masuoka N, Yamada M, Kira S, and Makino H. Catalase deficiency renders remnant kidneys more susceptible to oxidant tissue injury and renal fibrosis in mice. Kidney Int 68: 1018-1031, 2005.
141. Kobori H, Nangaku M, Navar LG, and Nishiyama A. The intrarenal renin-Angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 59: 251-287, 2007.
142. Kobori H, Nishiyama A, Abe Y, and Navar LG. Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet. Hypertension 41: 592-597, 2003.
143. Kohan DE, Padilla E, and Hughes AK. Endothelin B receptor mediates ET-1 effects on cAMP and PGE2 accumulation in rat IMCD. Am J Physiol 265: F670-F676, 1993.
144. Kondo T, Reaume AG, Huang TT, Carlson E, Murakami K, Chen SF, Hoffman EK, Scott RW, Epstein CJ, and Chan PH. Reduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischemia. J Neurosci 17: 4180-4189, 1997.
145. Kopp UC. Neural Control of Renal Function. San Rafael, CA: Morgan Claypool Life Sciences, 2011.
146. Kost CK, Jr., Herzer WA, Rominski BR, Mi Z, and Jackson EK. Diuretic response to adenosine A(1) receptor blockade in normotensive and spontaneously hypertensive rats: role of pertussis toxin-sensitive G-proteins. J Pharmacol Exp Ther 292: 752-760, 2000.
147. Kovacs G, Peti-Peterdi J, Rosivall L, and Bell PD. Angiotensin II directly stimulates macula densa Na-2Cl-K cotransport via apical AT(1) receptors. Am J Physiol Renal Physiol 282: F301-F306, 2002.
148. Kurtz A. Control of renin synthesis and secretion. Am J Hypertens 25: 839-847, 2012.
149. Kwon TH, Nielsen J, Kim YH, Knepper MA, Frokiaer J, and Nielsen S. Regulation of sodium transporters in the thick ascending limb of rat kidney: response to angiotensin II. Am J Physiol Renal Physiol 285: F152-F165, 2003.
150. Lai EY, Luo Z, Onozato ML, Rudolph EH, Solis G, Jose PA, Wellstein A, Aslam S, Quinn MT, Griendling K, Le T, Li P, Palm F, Welch WJ, and Wilcox CS. Effects of the antioxidant drug tempol on renal oxygenation in mice with reduced renal mass. Am J Physiol Renal Physiol 303: F64-F74, 2012.
151. Lai EY, Onozato ML, Solis G, Aslam S, Welch WJ, and Wilcox CS. Myogenic responses of mouse isolated perfused renal afferent arterioles: effects of salt intake and reduced renal mass. Hypertension 55: 983-989, 2010.
152. Lai EY, Patzak A, Steege A, Mrowka R, Brown R, Spielmann N, Persson PB, Fredholm BB, and Persson AE. Contribution of adenosine receptors in the control of arteriolar tone and adenosine-Angiotensin II interaction. Kidney Int 70: 690-698, 2006.
153. Lai EY, Solis G, Luo Z, Carlstrom M, Sandberg K, Holland S, Wellstein A, Welch WJ, and Wilcox CS. p47(phox) is required for afferent arteriolar contractile responses to angiotensin II and perfusion pressure in mice. Hypertension 59: 415-420, 2012.
154. Lai EY, Wellstein A, Welch WJ, and Wilcox CS. Superoxide modulates myogenic contractions of mouse afferent arterioles. Hypertension 58: 650-656, 2011.
155. Lebovitz RM, Zhang H, Vogel H, Cartwright J, Jr., Dionne L, Lu N, Huang S, and Matzuk MM. Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc Natl Acad Sci U S A 93: 9782-9787, 1996.
156. Lee DL, Bell TD, Bhupatkar J, Solis G, and Welch WJ. Adenosine A1-receptor knockout mice have a decreased blood pressure response to low-dose ANG II infusion. Am J Physiol Regul Integr Comp Physiol 303: R683-R688, 2012.
157. Leong PK, Devillez A, Sandberg MB, Yang LE, Yip DK, Klein JB, and McDonough AA. Effects of ACE inhibition on proximal tubule sodium transport. Am J Physiol Renal Physiol 290: F854-F863, 2006.
158. Leong PK, Zhang Y, Yang LE, Holstein-Rathlou NH, and McDonough AA. Diuretic response to acute hypertension is blunted during angiotensin II clamp. Am J Physiol Regul Integr Comp Physiol 283: R837-R842, 2002.
159. Lerman LO, Nath KA, Rodriguez-Porcel M, Krier JD, Schwartz RS, Napoli C, and Romero JC. Increased oxidative stress in experimental renovascular hypertension. Hypertension 37: 541-546, 2001.
160. Li L, Fink GD, Watts SW, Northcott CA, Galligan JJ, Pagano PJ, and Chen AF. Endothelin-1 increases vascular superoxide via endothelin(A)-NADPH oxidase pathway in low-renin hypertension. Circulation 107: 1053-1058, 2003.
161. Li L and Frei B. Iron chelation inhibits NF-kappaB-mediated adhesion molecule expression by inhibiting p22(phox) protein expression and NADPH oxidase activity. Arterioscler Thromb Vasc Biol 26: 2638-2643, 2006.
162. Li XC and Zhuo JL. Intracellular ANG II directly induces in vitro transcription of TGF-beta1, MCP-1, and NHE-3 mRNAs in isolated rat renal cortical nuclei via activation of nuclear AT1a receptors. Am J Physiol Cell Physiol 294: C1034-C1045, 2008.
163. Li Y, Huang TT, Carlson EJ, Melov S, Ursell PC, Olson JL, Noble LJ, Yoshimura MP, Berger C, Chan PH, Wallace DC, and Epstein CJ. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 11: 376-381, 1995.
164. Licea H, Walters MR, and Navar LG. Renal nuclear angiotensin II receptors in normal and hypertensive rats. Acta Physiol Hung 89: 427-438, 2002.
165. Liu R, Ren Y, Garvin JL, and Carretero OA. Superoxide enhances tubuloglomerular feedback by constricting the afferent arteriole. Kidney Int 66: 268-274, 2004.
166. Liu Y, Bubolz AH, Mendoza S, Zhang DX, and Gutterman DD. H2O2 is the transferrable factor mediating flow-induced dilation in human coronary arterioles. Circ Res 108: 566-573, 2011.
167. Lob HE, Vinh A, Li L, Blinder Y, Offermanns S, and Harrison DG. Role of vascular extracellular superoxide dismutase in hypertension. Hypertension 58: 232-239, 2011.
168. Lodha S, Dani D, Mehta R, Bhaskaran M, Reddy K, Ding G, and Singhal PC. Angiotensin II-induced mesangial cell apoptosis: role of oxidative stress. Mol Med 8: 830-840, 2002.
169. Loutzenhiser R, Griffin K, Williamson G, and Bidani A. Renal autoregulation: new perspectives regarding the protective and regulatory roles of the underlying mechanisms. Am J Physiol Regul Integr Comp Physiol 290: R1153-R1167, 2006.
170. Luo Z, Chen Y, Chen S, Welch WJ, Andresen BT, Jose PA, and Wilcox CS. Comparison of inhibitors of superoxide generation in vascular smooth muscle cells. Br J Pharmacol 157: 935-943, 2009.
171. Lurbe E, Redon J, Kesani A, Pascual JM, Tacons J, Alvarez V, and Batlle D. Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med 347: 797-805, 2002.
172. Lyle AN, Deshpande NN, Taniyama Y, Seidel-Rogol B, Pounkova L, Du P, Papaharalambus C, Lassegue B, and Griendling KK. Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circ Res 105: 249-259, 2009.
173. Lyon-Roberts B, Strait KA, van Peursem E, Kittikulsuth W, Pollock JS, Pollock DM, and Kohan DE. Flow regulation of collecting duct endothelin-1 production. Am J Physiol Renal Physiol 300: F650-F656, 2011.
174. Magyar CE, Zhang Y, Holstein-Rathlou NH, and McDonough AA. Proximal tubule Na transporter responses are the same during acute and chronic hypertension. Am J Physiol Renal Physiol 279: F358-F369, 2000.
175. Makino A, Skelton MM, Zou AP, and Cowley AW, Jr. Increased renal medullary H2O2 leads to hypertension. Hypertension 42: 25-30, 2003.
176. Makino A, Skelton MM, Zou AP, Roman RJ, and Cowley AW, Jr. Increased renal medullary oxidative stress produces hypertension. Hypertension 39: 667-672, 2002.
177. Mamenko M, Zaika O, Ilatovskaya DV, Staruschenko A, and Pochynyuk O. Angiotensin II increases activity of the epithelial Na+ channel (ENaC) in distal nephron additively to aldosterone. J Biol Chem 287: 660-671, 2012.
178. Manning RD, Jr., Hu L, and Reckelhoff JF. Role of nitric oxide in the arterial pressure and renal adaptations to longterm changes in sodium intake. Am J Physiol 272: R1162-R1169, 1997.
179. Manning RD, Jr., Meng S, and Tian N. Renal and vascular oxidative stress and salt-sensitivity of arterial pressure. Acta Physiol Scand 179: 243-250, 2003.
180. Manning RD, Jr., Tian N, and Meng S. Oxidative stress and antioxidant treatment in hypertension and the associated renal damage. Am J Nephrol 25: 311-317, 2005.
181. Marklund SL. Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species. Biochem J 222: 649-655, 1984.
182. Matavelli LC, Huang J, and Siragy HM. Angiotensin AT(2) receptor stimulation inhibits early renal inflammation in renovascular hypertension. Hypertension 57: 308-313, 2011.
183. Matsubara H, Sugaya T, Murasawa S, Nozawa Y, Mori Y, Masaki H, Maruyama K, Tsutumi Y, Shibasaki Y, Moriguchi Y, Tanaka Y, Iwasaka T, and Inada M. Tissuespecific expression of human angiotensin II AT1 and AT2 receptors and cellular localization of subtype mRNAs in adult human renal cortex using in situ hybridization. Nephron 80: 25-34, 1998.
184. Mazzali M, Jefferson JA, Ni Z, Vaziri ND, and Johnson RJ. Microvascular and tubulointerstitial injury associated with chronic hypoxia-induced hypertension. Kidney Int 63: 2088-2093, 2003.
185. McDonough AA. Mechanisms of proximal tubule sodium transport regulation that link extracellular fluid volume and blood pressure. Am J Physiol Regul Integr Comp Physiol 298: R851-R861, 2010.
186. Meng S, Cason GW, Gannon AW, Racusen LC, and Manning RD, Jr. Oxidative stress in Dahl salt-sensitive hypertension. Hypertension 41: 1346-1352, 2003.
187. Meng S, Roberts LJ, 2nd, Cason GW, Curry TS, and Manning RD, Jr. Superoxide dismutase and oxidative stress in Dahl salt-sensitive and -resistant rats. Am J Physiol Regul Integr Comp Physiol 283: R732-R738, 2002.
188. Mitchell KD and Navar LG. Enhanced tubuloglomerular feedback during peritubular infusions of angiotensins I and II. Am J Physiol 255: F383-F390, 1988.
189. Miyata K, Rahman M, Shokoji T, Nagai Y, Zhang GX, Sun GP, Kimura S, Yukimura T, Kiyomoto H, Kohno M, Abe Y, and Nishiyama A. Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells. J Am Soc Nephrol 16: 2906-2912, 2005.
190. Miyata N, Park F, Li XF, and Cowley AW, Jr. Distribution of angiotensin AT1 and AT2 receptor subtypes in the rat kidney. Am J Physiol 277: F437-F446, 1999.
191. Modlinger P, Chabrashvili T, Gill PS, Mendonca M, Harrison DG, Griendling KK, Li M, Raggio J, Wellstein A, Chen Y, Welch WJ, and Wilcox CS. RNA silencing in vivo reveals role of p22phox in rat angiotensin slow pressor response. Hypertension 47: 238-244, 2006.
192. Montezano AC and Touyz RM. Molecular mechanisms of hypertension-reactive oxygen species and antioxidants: a basic science update for the clinician. Can J Cardiol 28: 288-295, 2012.
193. Montezano AC and Touyz RM. Oxidative stress, Noxs, and hypertension: experimental evidence and clinical controversies. Ann Med 44 Suppl 1: S2-S16, 2012.
194. Moore LC, Schnermann J, and Yarimizu S. Feedback mediation of SNGFR autoregulation in hydropenic and DOCA-And salt-loaded rats. Am J Physiol 237: F63-F74, 1979.
195. Moreno C, Lopez A, Llinas MT, Rodriguez F, Lopez-Farre A, Nava E, and Salazar FJ. Changes in NOS activity and protein expression during acute and prolonged ANG II administration. Am J Physiol Regul Integr Comp Physiol 282: R31-R37, 2002.
196. Moreno C, Maier KG, Hoagland KM, Yu M, and Roman RJ. Abnormal pressure-natriuresis in hypertension: role of cytochrome P450 metabolites of arachidonic acid. Am J Hypertens 14: 90S-97S, 2001.
197. Mori T, Ogawa S, Cowely AW, Jr., and Ito S. Role of renal medullary oxidative and/or carbonyl stress in salt-sensitive hypertension and diabetes. Clin Exp Pharmacol Physiol 39: 125-131, 2012.
198. Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T, and Inoue M. Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci U S A 88: 10045-10048, 1991.
199. Nie J LQ, Chen S, Wilcox CS, and Welch WJ. Regulation of fluid reabsorption in the proximal tubule: role of nitric oxide, ADMA and DDAH. J Am Soc Nephrol 19: 23A, 2008.
200. Nie Z, Mei Y, Ford M, Rybak L, Marcuzzi A, Ren H, Stiles GL, and Ramkumar V. Oxidative stress increases A1 adenosine receptor expression by activating nuclear factor kappa B. Mol Pharmacol 53: 663-669, 1998.
201. Nishi A, Eklof AC, Bertorello AM, and Aperia A. Dopamine regulation of renal Na+ ,K( + )-ATPase activity is lacking in Dahl salt-sensitive rats. Hypertension 21: 767-771, 1993.
202. Nishiyama A, Yao L, Nagai Y, Miyata K, Yoshizumi M, Kagami S, Kondo S, Kiyomoto H, Shokoji T, Kimura S, Kohno M, and Abe Y. Possible contributions of reactive oxygen species and mitogen-Activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats. Hypertension 43: 841-848, 2004.
203. Nistala R, Wei Y, Sowers JR, and Whaley-Connell A. Reninangiotensin- Aldosterone system-mediated redox effects in chronic kidney disease. Transl Res 153: 102-113, 2009.
204. Nistala R, Whaley-Connell A, and Sowers JR. Redox control of renal function and hypertension. Antioxid Redox Signal 10: 2047-2089, 2008.
205. Nogueira EF, Xing Y, Morris CA, and Rainey WE. Role of angiotensin II-induced rapid response genes in the regu-lation of enzymes needed for aldosterone synthesis. J Mol Endocrinol 42: 319-330, 2009.
206. Norrelund H, Christensen KL, Samani NJ, Kimber P, Mulvany MJ, and Korsgaard N. Early narrowed afferent arteriole is a contributor to the development of hypertension. Hypertension 24: 301-308, 1994.
207. Nouri P, Gill P, Li M, Wilcox CS, and Welch WJ. p22phox in the macula densa regulates single nephron GFR during angiotensin II infusion in rats. Am J Physiol Heart Circ Physiol 292: H1685-H1689, 2007.
208. Nozik-Grayck E, Suliman HB, and Piantadosi CA. Extracellular superoxide dismutase. Int J Biochem Cell Biol 37: 2466-2471, 2005.
209. O?Connor PM and Cowley AW, Jr. Modulation of pressurenatriuresis by renal medullary reactive oxygen species and nitric oxide. Curr Hypertens Rep 12: 86-92, 2010.
210. Oberley TD, Coursin DB, Cihla HP, Oberley LW, el-Sayyad N, and Ho YS. Immunolocalization of manganese superoxide dismutase in normal and transgenic mice expressing the human enzyme. Histochem J 25: 267-279, 1993.
211. Oberley TD, Verwiebe E, Zhong W, Kang SW, and Rhee SG. Localization of the thioredoxin system in normal rat kidney. Free Radic Biol Med 30: 412-424, 2001.
212. Ogawa Y, Mukoyama M, Yokoi H, Kasahara M, Mori K, Kato Y, Kuwabara T, Imamaki H, Kawanishi T, Koga K, Ishii A, Tokudome T, Kishimoto I, Sugawara A, and Nakao K. Natriuretic Peptide receptor guanylyl cyclase-A protects podocytes from aldosterone-induced glomerular injury. J Am Soc Nephrol 23: 1198-1209, 2012.
213. Ohsaki Y, O?Connor P, Mori T, Ryan RP, Dickinson BC, Chang CJ, Lu Y, Ito S, and Cowley AW, Jr. Increase of sodium delivery stimulates the mitochondrial respiratory chain H2O2 production in rat renal medullary thick ascending limb. Am J Physiol Renal Physiol 302: F95-F102, 2012.
214. Ollerstam A, Pittner J, Persson AE, and Thorup C. Increased blood pressure in rats after long-term inhibition of the neuronal isoform of nitric oxide synthase. J Clin Invest 99: 2212-2218, 1997.
215. Ookawara T, Imazeki N, Matsubara O, Kizaki T, Oh-Ishi S, Nakao C, Sato Y, and Ohno H. Tissue distribution of immunoreactive mouse extracellular superoxide dismutase. Am J Physiol 275: C840-C847, 1998.
216. Ortiz MC, Manriquez MC, Romero JC, and Juncos LA. Antioxidants block angiotensin II-induced increases in blood pressure and endothelin. Hypertension 38: 655-659, 2001.
217. Ortiz PA and Garvin JL. Role of nitric oxide in the regulation of nephron transport. Am J Physiol Renal Physiol 282: F777-F784, 2002.
218. Ortiz PA, Hong NJ, and Garvin JL. NO decreases thick ascending limb chloride absorption by reducing Na( + )-K( + )-2Cl(-) cotransporter activity. Am J Physiol Renal Physiol 281: F819-F825, 2001.
219. Ortiz PA, Hong NJ, Wang D, and Garvin JL. Gene transfer of eNOS to the thick ascending limb of eNOS-KO mice restores the effects of L-Arginine on NaCl absorption. Hypertension 42: 674-679, 2003.
220. Ouyang X, Le TH, Roncal C, Gersch C, Herrera-Acosta J, Rodriguez-Iturbe B, Coffman TM, Johnson RJ, and Mu W. Th1 inflammatory response with altered expression of profibrotic and vasoactive mediators in AT1A and AT1B double-knockout mice. Am J Physiol Renal Physiol 289: F902-F910, 2005.
221. Ozono R, Wang ZQ, Moore AF, Inagami T, Siragy HM, and Carey RM. Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension 30: 1238-1246, 1997.
222. Pallone TL and Mattson DL. Role of nitric oxide in regulation of the renal medulla in normal and hypertensive kidneys. Curr Opin Nephrol Hypertens 11: 93-98, 2002.
223. Palm F, Onozato M, Welch WJ, and Wilcox CS. Blood pressure, blood flow, and oxygenation in the clipped kidney of chronic 2-kidney, 1-clip rats: effects of tempol and Angiotensin blockade. Hypertension 55: 298-304, 2010.
224. Panico C, Luo Z, Damiano S, Artigiano F, Gill P, and Welch WJ. Renal proximal tubular reabsorption is reduced in adult spontaneously hypertensive rats: roles of superoxide and Na+/H+ exchanger 3. Hypertension 54: 1291-1297, 2009.
225. Patel K, Chen Y, Dennehy K, Blau J, Connors S, Mendonca M, Tarpey M, Krishna M, Mitchell JB, Welch WJ, and Wilcox CS. Acute antihypertensive action of nitroxides in the spontaneously hypertensive rat. Am J Physiol Regul Integr Comp Physiol 290: R37-R43, 2006.
226. Patzak A, Lai E, Persson PB, and Persson AE. Angiotensin II-nitric oxide interaction in glomerular arterioles. Clin Exp Pharmacol Physiol 32: 410-414, 2005.
227. Pendergrass KD, Averill DB, Ferrario CM, Diz DI, and Chappell MC. Differential expression of nuclear AT1 receptors and angiotensin II within the kidney of the male congenic mRen2. Lewis rat. Am J Physiol Renal Physiol 290: F1497-F1506, 2006.
228. Pendergrass KD, Gwathmey TM, Michalek RD, Grayson JM, and Chappell MC. The angiotensin II-AT1 receptor stimulates reactive oxygen species within the cell nucleus. Biochem Biophys Res Commun 384: 149-154, 2009.
229. Peti-Peterdi J and Harris RC. Macula densa sensing and signaling mechanisms of renin release. J Am Soc Nephrol 21: 1093-1096, 2010.
230. Ploth DW, Schnermann J, Dahlheim H, Hermle M, and Schmidmeier E. Autoregulation and tubuloglomerular feedback in normotensive and hypertensive rats. Kidney Int 12: 253-267, 1977.
231. Pollock CA, Lawrence JR, and Field MJ. Tubular sodium handling and tubuloglomerular feedback in experimental diabetes mellitus. Am J Physiol 260: F946-F952, 1991.
232. Qi Z, Cai H, Morrow JD, and Breyer MD. Differentiation of cyclooxygenase 1-And 2-derived prostanoids in mouse kidney and aorta. Hypertension 48: 323-328, 2006.
233. Racasan S, Joles JA, Boer P, Koomans HA, and Braam B. NO dependency of RBF and autoregulation in the spontaneously hypertensive rat. Am J Physiol Renal Physiol 285: F105-F112, 2003.
234. Rajamohan SB, Raghuraman G, Prabhakar NR, and Kumar GK. NADPH oxidase-derived H(2)O(2) contributes to angiotensin II-induced aldosterone synthesis in human and rat adrenal cortical cells. Antioxid Redox Signal 17: 445-459, 2012.
235. Ren Y, D?Ambrosio MA, Garvin JL, and Carretero OA. Angiotensin II enhances connecting tubule glomerular feedback. Hypertension 56: 636-642, 2010.
236. Ren Y, D?Ambrosio MA, Liu R, Pagano PJ, Garvin JL, and Carretero OA. Enhanced myogenic response in the afferent arteriole of spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 298: H1769-H1775, 2010.
237. Ren Y, D?Ambrosio MA, Wang H, Peterson EL, Garvin JL, and Carretero OA. Mechanisms of angiotensin II-enhanced connecting tubule glomerular feedback. Am J Physiol Renal Physiol 303: F259-F265, 2012.
238. Ren Y, Garvin JL, and Carretero OA. Efferent arteriole tubuloglomerular feedback in the renal nephron. Kidney Int 59: 222-229, 2001.
239. Ren Z, Liang W, Chen C, Yang H, Singhal PC, and Ding G. Angiotensin II induces nephrin dephosphorylation and podocyte injury: role of caveolin-1. Cell Signal 24: 443-450, 2012.
240. Roberts LJ, 2nd, and Milne GL. Isoprostanes. J Lipid Res 50 Suppl: S219-S223, 2009.
241. Rocha R, Chander PN, Zuckerman A, and Stier CT, Jr. Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats. Hypertension 33: 232-237, 1999.
242. Rodrigo R, Gonzalez J, and Paoletto F. The role of oxidative stress in the pathophysiology of hypertension. Hypertens Res 34: 431-440, 2011.
243. Rodriguez-Iturbe B, Sepassi L, Quiroz Y, Ni Z, Wallace DC, and Vaziri ND. Association of mitochondrial SOD deficiency with salt-sensitive hypertension and accelerated renal senescence. J Appl Physiol 102: 255-260, 2007.
244. Roman RJ. Pressure-diuresis in volume-expanded rats. Tubular reabsorption in superficial and deep nephrons. Hypertension 12: 177-183, 1988.
245. Sainz J, Wangensteen R, Rodriguez Gomez I, Moreno JM, Chamorro V, Osuna A, Bueno P, and Vargas F. Antioxidant enzymes and effects of tempol on the development of hypertension induced by nitric oxide inhibition. Am J Hypertens 18: 871-877, 2005.
246. Sakamoto A, Hongo M, Saito K, Nagai R, and Ishizaka N. Reduction of renal lipid content and proteinuria by a PPAR-gamma agonist in a rat model of angiotensin II-induced hypertension. Eur J Pharmacol 682: 131-136, 2012.
247. Salmond R and Seney FD, Jr. Reset tubuloglomerular feedback permits and sustains glomerular hyperfunction after extensive renal ablation. Am J Physiol 260: F395-F401, 1991.
248. Sasamura H, Hein L, Krieger JE, Pratt RE, Kobilka BK, and Dzau VJ. Cloning, characterization, and expression of two angiotensin receptor (AT-1) isoforms from the mouse genome. Biochem Biophys Res Commun 185: 253-259, 1992.
249. Schlondorff D and Banas B. The mesangial cell revisited: no cell is an island. J Am Soc Nephrol 20: 1179-1187, 2009.
250. Schnackenberg CG. Physiological and pathophysiological roles of oxygen radicals in the renal microvasculature. Am J Physiol Regul Integr Comp Physiol 282: R335-R342, 2002.
251. Schnackenberg CG and Wilcox CS. Two-week administration of tempol attenuates both hypertension and renal excretion of 8-Iso prostaglandin f2alpha. Hypertension 33: 424-428, 1999.
252. Schnermann J, Gokel M, Weber PC, Schubert G, and Briggs JP. Tubuloglomerular feedback and glomerular morphology in Goldblatt hypertensive rats on varying protein diets. Kidney Int 29: 520-529, 1986.
253. Schnermann JB, Traynor T, Yang T, Huang YG, Oliverio MI, Coffman T, and Briggs JP. Absence of tubuloglomerular feedback responses in AT1A receptor-deficient mice. Am J Physiol 273: F315-F320, 1997.
254. Schreck C and O?Connor PM. NAD(P)H oxidase and renal epithelial ion transport. Am J Physiol Regul Integr Comp Physiol 300: R1023-R1029, 2011.
255. Sedeek M, Hebert RL, Kennedy CR, Burns KD, and Touyz RM. Molecular mechanisms of hypertension: role of Nox family NADPH oxidases. Curr Opin Nephrol Hypertens 18: 122-127, 2009.
256. Seeliger E, Wronski T, Ladwig M, Dobrowolski L, Vogel T, Godes M, Persson PB, and Flemming B. The reninangiotensin system and the third mechanism of renal blood flow autoregulation. Am J Physiol Renal Physiol 296: F1334-F1345, 2009.
257. Sentman ML, Granstrom M, Jakobson H, Reaume A, Basu S, and Marklund SL. Phenotypes of mice lacking extracellular superoxide dismutase and copper-And zinc-containing superoxide dismutase. J Biol Chem 281: 6904-6909, 2006.
258. Shibata S, Mu S, Kawarazaki H, Muraoka K, Ishizawa K, Yoshida S, Kawarazaki W, Takeuchi M, Ayuzawa N, Miyoshi J, Takai Y, Ishikawa A, Shimosawa T, Ando K, Nagase M, and Fujita T. Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway. J Clin Invest 121: 3233-3243, 2011.
259. Shibata S, Nagase M, Yoshida S, Kawachi H, and Fujita T. Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1. Hypertension 49: 355-364, 2007.
260. Shibata S, Nagase M, Yoshida S, Kawarazaki W, Kurihara H, Tanaka H, Miyoshi J, Takai Y, and Fujita T. Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease. Nat Med 14: 1370-1376, 2008.
261. Shokoji T, Nishiyama A, Fujisawa Y, Hitomi H, Kiyomoto H, Takahashi N, Kimura S, Kohno M, and Abe Y. Renal sympathetic nerve responses to tempol in spontaneously hypertensive rats. Hypertension 41: 266-273, 2003.
262. Sigmon DH and Beierwaltes WH. Degree of renal artery stenosis alters nitric oxide regulation of renal hemodynamics. J Am Soc Nephrol 5: 1369-1377, 1994.
263. Sigmon DH and Beierwaltes WH. Influence of nitric oxide in the chronic phase of two-kidney, one clip renovascular hypertension. Hypertension 31: 649-656, 1998.
264. Silva GB, Ortiz PA, Hong NJ, and Garvin JL. Superoxide stimulates NaCl absorption in the thick ascending limb via activation of protein kinase C. Hypertension 48: 467-472, 2006.
265. Simao S, Gomes P, Pinto V, Silva E, Amaral JS, Igreja B, Afonso J, Serrao MP, Pinho MJ, and Soares-da-Silva P. Agerelated changes in renal expression of oxidant and antioxidant enzymes and oxidative stress markers in male SHR and WKY rats. Exp Gerontol 46: 468-474, 2011.
266. Skov K and Mulvany MJ. Structure of renal afferent arterioles in the pathogenesis of hypertension. Acta Physiol Scand 181: 397-405, 2004.
267. Sousa T, Oliveira S, Afonso J, Morato M, Patinha D, Fraga S, Carvalho F, and Albino-Teixeira A. Role of H(2) O(2) in hypertension, renin-Angiotensin system activation and renal medullary disfunction caused by angiotensin II. Br J Pharmacol 166: 2386-2401, 2012.
268. Sousa T, Pinho D, Morato M, Marques-Lopes J, Fernandes E, Afonso J, Oliveira S, Carvalho F, and Albino-Teixeira A. Role of superoxide and hydrogen peroxide in hypertension induced by an antagonist of adenosine receptors. Eur J Pharmacol 588: 267-276, 2008.
269. Speed JS, LaMarca B, Berry H, Cockrell K, George EM, and Granger JP. Renal medullary endothelin-1 is decreased in Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 301: R519-R523, 2011.
270. Stier CT, Jr., Itskovitz HD, and Chen YH. Urinary dopamine and sodium excretion in spontaneously hypertensive rats. Clin Exp Hypertens 15: 105-123, 1993.
271. Strojek K, Grzeszczak W, Lacka B, Gorska J, Keller CK, and Ritz E. Increased prevalence of salt sensitivity of blood pressure in IDDM with and without microalbuminuria. Diabetologia 38: 1443-1448, 1995.
272. Sun P, Yue P, and Wang WH. Angiotensin II stimulates epithelial sodium channels in the cortical collecting duct of the rat kidney. Am J Physiol Renal Physiol 302: F679-F687, 2012.
273. Sun Y, Zhang JN, Zhao D, Wang QS, Gu YC, Ma HP, and Zhang ZR. Role of the epithelial sodium channel in saltsensitive hypertension. Acta Pharmacol Sin 32: 789-797, 2011.
274. Suzuki K, Han GD, Miyauchi N, Hashimoto T, Nakatsue T, Fujioka Y, Koike H, Shimizu F, and Kawachi H. Angiotensin II type 1 and type 2 receptors play opposite roles in regulating the barrier function of kidney glomerular capillary wall. Am J Pathol 170: 1841-1853, 2007.
275. Szentivanyi M, Jr., Zou AP, Mattson DL, Soares P, Moreno C, Roman RJ, and Cowley AW, Jr. Renal medullary nitric oxide deficit of Dahl S rats enhances hypertensive actions of angiotensin II. Am J Physiol Regul Integr Comp Physiol 283: R266-R272, 2002.
276. Tang Y and Zhou L. Characterization of adenosine A1 receptors in human proximal tubule epithelial (HK-2) cells. Receptors Channels 9: 67-75, 2003.
277. Tanito M, Nakamura H, Kwon YW, Teratani A, Masutani H, Shioji K, Kishimoto C, Ohira A, Horie R, and Yodoi J. Enhanced oxidative stress and impaired thioredoxin expression in spontaneously hypertensive rats. Antioxid Redox Signal 6: 89-97, 2004.
278. Thaete LG, Crouch RK, Schulte BA, and Spicer SS. The immunolocalization of copper-zinc superoxide dismutase in canine tissues. J Histochem Cytochem 31: 1399-1406, 1983.
279. Thaete LG, Crouch RK, and Spicer SS. Immunolocalization of copper-zinc superoxide dismutase. II. Rat. J Histochem Cytochem 33: 803-808, 1985.
280. Thomas D, Harris PJ, and Morgan TO. Age-related changes in angiotensin II-stimulated proximal tubule fluid reabsorption in the spontaneously hypertensive rat. J Hypertens Suppl 6: S449-S451, 1988.
281. Thomas SR, Witting PK, and Drummond GR. Redox control of endothelial function and dysfunction: molecular mechanisms and therapeutic opportunities. Antioxid Redox Signal 10: 1713-1765, 2008.
282. Thomson SC, Vallon V, and Blantz RC. Resetting protects efficiency of tubuloglomerular feedback. Kidney Int Suppl 67: S65-S70, 1998.
283. Tian XY, Wong WT, Leung FP, Zhang Y, Wang YX, Lee HK, Ng CF, Chen ZY, Yao X, Au CL, Lau CW, Vanhoutte PM, Cooke JP, and Huang Y. Oxidative stress-dependent cyclooxygenase-2-derived prostaglandin f(2alpha) impairs endothelial function in renovascular hypertensive rats. Antioxid Redox Signal 16: 363-373, 2012.
284. Toda N and Okamura T. Modulation of renal blood flow and vascular tone by neuronal nitric oxide synthasederived nitric oxide. J Vasc Res 48: 1-10, 2011.
285. Tomaschitz A, Pilz S, Ritz E, Obermayer-Pietsch B, and Pieber TR. Aldosterone and arterial hypertension. Nat Rev Endocrinol 6: 83-93, 2010.
286. Troncoso Brindeiro CM, Lane PH, and Carmines PK. Tempol prevents altered K( + ) channel regulation of afferent arteriolar tone in diabetic rat kidney. Hypertension 59: 657-664, 2012.
287. Valentin F, Field MC, and Tippins JR. The mechanism of oxidative stress stabilization of the thromboxane receptor in COS-7 cells. J Biol Chem 279: 8316-8324, 2004.
288. Vallon V, Traynor T, Barajas L, Huang YG, Briggs JP, and Schnermann J. Feedback control of glomerular vascular tone in neuronal nitric oxide synthase knockout mice. J Am Soc Nephrol 12: 1599-1606, 2001.
289. Van Remmen H, Ikeno Y, Hamilton M, Pahlavani M, Wolf N, Thorpe SR, Alderson NL, Baynes JW, Epstein CJ, Huang TT, Nelson J, Strong R, and Richardson A. Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol Genomics 16: 29-37, 2003.
290. Van Remmen H, Salvador C, Yang H, Huang TT, Epstein CJ, and Richardson A. Characterization of the antioxidant status of the heterozygous manganese superoxide dismutase knockout mouse. Arch Biochem Biophys 363: 91-97, 1999.
291. Vanhoutte PM, Feletou M, and Taddei S. Endotheliumdependent contractions in hypertension. Br J Pharmacol 144: 449-458, 2005.
292. Vaziri ND, Wang XQ, Oveisi F, and Rad B. Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension 36: 142-146, 2000.
293. Wang D, Chabrashvili T, and Wilcox CS. Enhanced contractility of renal afferent arterioles from angiotensin-infused rabbits: roles of oxidative stress, thromboxane prostanoid receptors, and endothelium. Circ Res 94: 1436-1442, 2004.
294. Wang D, Chen Y, Chabrashvili T, Aslam S, Borrego Conde LJ, Umans JG, and Wilcox CS. Role of oxidative stress in endothelial dysfunction and enhanced responses to angiotensin II of afferent arterioles from rabbits infused with angiotensin II. J Am Soc Nephrol 14: 2783-2789, 2003.
295. Wang D, Jose P, and Wilcox CS. beta(1) Receptors protect the renal afferent arteriole of angiotensin-infused rabbits from norepinephrine-induced oxidative stress. J Am Soc Nephrol 17: 3347-3354, 2006.
296. Wang H, D?Ambrosio MA, Garvin JL, Ren Y, and Carretero OA. Connecting tubule glomerular feedback mediates acute tubuloglomerular feedback resetting. Am J Physiol Renal Physiol 302: F1300-F1304, 2012.
297. Wang H, Garvin JL, D?Ambrosio MA, Ren Y, and Carretero OA. Connecting tubule glomerular feedback antagonizes tubuloglomerular feedback in vivo. Am J Physiol Renal Physiol 299: F1374-F1378, 2010.
298. Wang T. Role of iNOS and eNOS in modulating proximal tubule transport and acid-base balance. Am J Physiol Renal Physiol 283: F658-F662, 2002.
299. Wang T, Inglis FM, and Kalb RG. Defective fluid and HCO(3)( -) absorption in proximal tubule of neuronal nitric oxide synthase-knockout mice. Am J Physiol Renal Physiol 279: F518-F524, 2000.
300. Wang X, Escano CS, Asico L, Jones JE, Barte A, and Jose PA. Upregulation of renal D5 dopamine receptor ameliorates hypertension in D3-deficient mice. High Blood Pressure Council Research 2012 Scientific Sessions 133, 2012.
301. Welch WJ, Baumgartl H, Lubbers D, and Wilcox CS. Nephron pO2 and renal oxygen usage in the hypertensive rat kidney. Kidney Int 59: 230-237, 2001.
302. Welch WJ, Baumgartl H, Lubbers D, and Wilcox CS. Renal oxygenation defects in the spontaneously hypertensive rat: role of AT1 receptors. Kidney Int 63: 202-208, 2003.
303. Welch WJ, Blau J, Xie H, Chabrashvili T, and Wilcox CS. Angiotensin-induced defects in renal oxygenation: role of oxidative stress. Am J Physiol Heart Circ Physiol 288: H22-H28, 2005.
304. Welch WJ, Chabrashvili T, Solis G, Chen Y, Gill PS, Aslam S, Wang X, Ji H, Sandberg K, Jose P, and Wilcox CS. Role of extracellular superoxide dismutase in the mouse angiotensin slow pressor response. Hypertension 48: 934-941, 2006.
305. Welch WJ, Mendonca M, Aslam S, and Wilcox CS. Roles of oxidative stress and AT1 receptors in renal hemodynamics and oxygenation in the postclipped 2K,1C kidney. Hypertension 41: 692-696, 2003.
306. Welch WJ, Mendonca M, Blau J, Karber A, Dennehy K, Patel K, Lao YS, Jose PA, and Wilcox CS. Antihypertensive response to prolonged tempol in the spontaneously hypertensive rat. Kidney Int 68: 179-187, 2005.
307. Welch WJ, Ott CE, Guthrie GP, Jr., and Kotchen TA. Mechanism of increased renin release in the adrenalectomized rat. Adrenal insufficiency and renin. Hypertension 5: I47-I52, 1983.
308. Welch WJ, Patel K, Modlinger P, Mendonca M, Kawada N, Dennehy K, Aslam S, and Wilcox CS. Roles of vasoconstrictor prostaglandins, COX-1 and -2, and AT1, AT2, and TP receptors in a rat model of early 2K,1C hypertension. Am J Physiol Heart Circ Physiol 293: H2644-H2649, 2007.
309. Welch WJ, Tojo A, Lee JU, Kang DG, Schnackenberg CG, and Wilcox CS. Nitric oxide synthase in the JGA of the SHR: expression and role in tubuloglomerular feedback. Am J Physiol 277: F130-F138, 1999.
310. Welch WJ, Tojo A, and Wilcox CS. Roles of NO and oxygen radicals in tubuloglomerular feedback in SHR. Am J Physiol Renal Physiol 278: F769-F776, 2000.
311. Welch WJ and Wilcox CS. Potentiation of tubuloglomerular feedback in the rat by thromboxane mimetic. Role of macula densa. J Clin Invest 89: 1857-1865, 1992.
312. Welch WJ and Wilcox CS. AT1 receptor antagonist combats oxidative stress and restores nitric oxide signaling in the SHR. Kidney Int 59: 1257-1263, 2001.
313. Wharram BL, Goyal M, Wiggins JE, Sanden SK, Hussain S, Filipiak WE, Saunders TL, Dysko RC, Kohno K, Holzman LB, and Wiggins RC. Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 16: 2941-2952, 2005.
314. Widder JD, Fraccarollo D, Galuppo P, Hansen JM, Jones DP, Ertl G, and Bauersachs J. Attenuation of angiotensin II-induced vascular dysfunction and hypertension by overexpression of Thioredoxin 2. Hypertension 54: 338-344, 2009.
315. Wilcox CS. Reactive oxygen species: roles in blood pressure and kidney function. Curr Hypertens Rep 4: 160-166, 2002.
316. Wilcox CS. Redox regulation of the afferent arteriole and tubuloglomerular feedback. Acta Physiol Scand 179: 217-223, 2003.
317. Wilcox CS. Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? Am J Physiol Regul Integr Comp Physiol 289: R913-R935, 2005.
318. Wilcox CS. Effects of tempol and redox-cycling nitroxides in models of oxidative stress. Pharmacol Ther 126: 119-145, 2010.
319. Wilcox CS and Pearlman A. Chemistry and antihypertensive effects of tempol and other nitroxides. Pharmacol Rev 60: 418-469, 2008.
320. Wilcox CS and Welch WJ. Macula densa nitric oxide synthase: expression, regulation, and function. Kidney Int Suppl 67: S53-S57, 1998.
321. Wilcox CS and Welch WJ. Oxidative stress: cause or consequence of hypertension. Exp Biol Med (Maywood) 226: 619-620, 2001.
322. Wilcox CS, Welch WJ, Murad F, Gross SS, Taylor G, Levi R, and Schmidt HH. Nitric oxide synthase in macula densa regulates glomerular capillary pressure. Proc Natl Acad Sci U S A 89: 11993-11997, 1992.
323. Wilcox CS, Welch WJ, Schreiner GF, and Belardinelli L. Natriuretic and diuretic actions of a highly selective adenosine A1 receptor antagonist. J Am Soc Nephrol 10: 714-720, 1999.
324. Williams JM, Sarkis A, Hoagland KM, Fredrich K, Ryan RP, Moreno C, Lopez B, Lazar J, Fenoy FJ, Sharma M, Garrett MR, Jacob HJ, and Roman RJ. Transfer of the CYP4A region of chromosome 5 from Lewis to Dahl S rats attenuates renal injury. Am J Physiol Renal Physiol 295: F1764-F1777, 2008.
325. Xu H, Fink GD, Chen A, Watts S, and Galligan JJ. Nitric oxide-independent effects of tempol on sympathetic nerve activity and blood pressure in normotensive rats. Am J Physiol Heart Circ Physiol 281: H975-H980, 2001.
326. Xu H, Fink GD, and Galligan JJ. Nitric oxide-independent effects of tempol on sympathetic nerve activity and blood pressure in DOCA-salt rats. Am J Physiol Heart Circ Physiol 283: H885-H892, 2002.
327. Xu H, Fink GD, and Galligan JJ. Tempol lowers blood pressure and sympathetic nerve activity but not vascular O2-in DOCA-salt rats. Hypertension 43: 329-334, 2004.
328. Xu L, Dixit MP, Chen R, Dixit NM, Collins JF, and Ghishan FK. Effects of angiotensin II on NaPi-IIa co-transporter expression and activity in rat renal cortex. Biochim Biophys Acta 1667: 114-121, 2004.
329. Yadav A, Vallabu S, Arora S, Tandon P, Slahan D, Teichberg S, and Singhal PC. ANG II promotes autophagy in podocytes. Am J Physiol Cell Physiol 299: C488-C496, 2010.
330. Yalavarthy R, Smith ML, and Edelstein C. Acute kidney injury complicating minimal change disease: the case for careful use of diuretics and
331. Yang H, Shi M, VanRemmen H, Chen X, Vijg J, Richardson A, and Guo Z. Reduction of pressor response to vasoconstrictor agents by overexpression of catalase in mice. Am J Hypertens 16: 1-5, 2003.
332. Yang J, Chen C, Ren H, Han Y, He D, Zhou L, Hopfer U, Jose PA, and Zeng C. Angiotensin II AT(2) receptor decreases AT(1) receptor expression and function via nitric oxide/cGMP/Sp1 in renal proximal tubule cells from Wistar-Kyoto rats. J Hypertens 30: 1176-1184, 2012.
333. Yang J, Pollock JS, and Carmines PK. NADPH oxidase and PKC contribute to increased Na transport by the thick ascending limb during type 1 diabetes. Hypertension 59: 431-436, 2012.
334. Yang LE, Leong PK, and McDonough AA. Reducing blood pressure in SHR with enalapril provokes redistribution of NHE3, NaPi2, and NCC and decreases NaPi2 and ACE abundance. Am J Physiol Renal Physiol 293: F1197-F1208, 2007.
335. Yang Z, Asico LD, Yu P, Wang Z, Jones JE, Escano CS, Wang X, Quinn MT, Sibley DR, Romero GG, Felder RA, and Jose PA. D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. Am J Physiol Regul Integr Comp Physiol 290: R96-R104, 2006.
336. Ye S, Gamburd M, Mozayeni P, Koss M, and Campese VM. A limited renal injury may cause a permanent form of neurogenic hypertension. Am J Hypertens 11: 723-728, 1998.
337. Ye S, Zhong H, Yanamadala S, and Campese VM. Oxidative stress mediates the stimulation of sympathetic nerve activity in the phenol renal injury model of hypertension. Hypertension 48: 309-315, 2006.
338. Yip KP, Tse CM, McDonough AA, and Marsh DJ. Redistribution of Na +/H+ exchanger isoform NHE3 in proximal tubules induced by acute and chronic hypertension. Am J Physiol 275: F565-F575, 1998.
339. Yoshimura M, Kambara S, Okabayashi H, Takahashi H, and Ijichi H. Effect of decreased dopamine synthesis on the development of hypertension induced by salt loading in spontaneously hypertensive rats. Clin Exp Hypertens A 9: 1141-1157, 1987.
340. Yu L, Bao HF, Self JL, Eaton DC, and Helms MN. Aldosterone-induced increases in superoxide production counters nitric oxide inhibition of epithelial Na channel activity in A6 distal nephron cells. Am J Physiol Renal Physiol 293: F1666-F1677, 2007.
341. Zatz R and Baylis C. Chronic nitric oxide inhibition model six years on. Hypertension 32: 958-964, 1998.
342. Zelko IN and Folz RJ. Extracellular superoxide dismutase functions as a major repressor of hypoxia-induced erythropoietin gene expression. Endocrinology 146: 332-340, 2005.
343. Zeng C and Jose PA. Dopamine receptors: important antihypertensive counterbalance against hypertensive factors. Hypertension 57: 11-17, 2011.
344. Zeng C, Liu Y, Wang Z, He D, Huang L, Yu P, Zheng S, Jones JE, Asico LD, Hopfer U, Eisner GM, Felder RA, and Jose PA. Activation of D3 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells. Circ Res 99: 494-500, 2006.
345. Zeng C, Yang Z, Wang Z, Jones J, Wang X, Altea J, Mangrum AJ, Hopfer U, Sibley DR, Eisner GM, Felder RA, and Jose PA. Interaction of angiotensin II type 1 and D5 dopamine receptors in renal proximal tubule cells. Hypertension 45: 804-810, 2005.
346. Zhan CD, Sindhu RK, Pang J, Ehdaie A, and Vaziri ND. Superoxide dismutase, catalase and glutathione peroxidase in the spontaneously hypertensive rat kidney: effect of antioxidant-rich diet. J Hypertens 22: 2025-2033, 2004.
347. Zhang H, Luo Y, Zhang W, He Y, Dai S, Zhang R, Huang Y, Bernatchez P, Giordano FJ, Shadel G, Sessa WC, and Min W. Endothelial-specific expression of mitochondrial thioredoxin improves endothelial cell function and reduces atherosclerotic lesions. Am J Pathol 170: 1108-1120, 2007.
348. Zhang Z, Rhinehart K, Solis G, Pittner J, Lee-Kwon W, Welch WJ, Wilcox CS, and Pallone TL. Chronic ANG II infusion increases NO generation by rat descending vasa recta. Am J Physiol Heart Circ Physiol 288: H29-H36, 2005.
349. Zhou Y and Boron WF. Role of endogenously secreted angiotensin II in the CO2-induced stimulation of HCO3 reabsorption by renal proximal tubules. Am J Physiol Renal Physiol 294: F245-F252, 2008.
350. Zoccali C. The endothelium as a target in renal diseases. J Nephrol 20 Suppl 12: S39-S44, 2007.
351. Zou AP, Wu F, and Cowley AW, Jr. Protective effect of angiotensin II-induced increase in nitric oxide in the renal medullary circulation. Hypertension 31: 271-276, 1998.